---
title: "Compass Point 坚持对 Antalpha Platform Holding Company (ANTA) 的买入评级"
description: "根据 TipRanks 的数据，Engel 在 10072 名分析师中排名第 3441 位。市场普遍认为，Antalpha 平台控股公司的分析师共识评级为适度买入，平均目标价格为 19.25 美元"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/264066053.md"
published_at: "2025-11-03T17:15:34.000Z"
---

# Compass Point 坚持对 Antalpha Platform Holding Company (ANTA) 的买入评级

> 根据 TipRanks 的数据，Engel 在 10072 名分析师中排名第 3441 位。市场普遍认为，Antalpha 平台控股公司的分析师共识评级为适度买入，平均目标价格为 19.25 美元

根据 TipRanks 的数据，Engel 在 10072 名分析师中排名第 3441。

市场普遍认为，Antalpha Platform Holding Company 的分析师共识评级为适度买入，平均目标价为 19.25 美元。

### Related Stocks

- [ANTA.US - Antalpha](https://longbridge.com/zh-CN/quote/ANTA.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| REG - ING Bank N.V. London - Post Stabilisation Notice - ING DiBa | ING Bank N.V. has issued a Post-Stabilisation Notice regarding the offering of EUR 750m Pfandbrief securities by ING-DiB | [Link](https://longbridge.com/zh-CN/news/276067141.md) |
| ING Strengthens Its Position  in The Swiss Market | ING is enhancing its presence in the Swiss market amid geopolitical uncertainties and supply chain challenges. The bank  | [Link](https://longbridge.com/zh-CN/news/276412254.md) |
| ProShare Advisors LLC Acquires 11,956 Shares of FormFactor, Inc. $FORM | ProShare Advisors LLC increased its stake in FormFactor, Inc. by 68.8% in Q3, acquiring 11,956 shares, bringing its tota | [Link](https://longbridge.com/zh-CN/news/276049513.md) |
| Unpacking the Latest Options Trading Trends in FormFactor | High-rolling investors are bearish on FormFactor (NASDAQ:FORM), with 76% of options trades indicating a negative sentime | [Link](https://longbridge.com/zh-CN/news/275941129.md) |
| Cervomed’S Neflamapimod Elected For Inclusion In Uk Experts-Als Platform | CervoMed Inc :CERVOMED’S NEFLAMAPIMOD ELECTED FOR INCLUSION IN UK EXPERTS-ALS PLATFORM DESIGNED TO PRIORITIZE PROMISING  | [Link](https://longbridge.com/zh-CN/news/276219812.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。